|
|
||||||||
1 Department of Pathology and Laboratory Medicine and 2 Department of Psychiatry, University of Cincinnati, Cincinnati, Ohio 45267-0529
We determined apolipoprotein AIV (apo AIV) content in intestinal epithelial cells using immunohistochemistry when leptin was administered intravenously. Most of the apo AIV immunoreactivity in the untreated intestine was located in the villous cells as opposed to the crypt cells. Regional distribution of apo AIV immunostaining revealed low apo AIV content in the duodenum and high content in the jejunum that gradually decreases caudally toward the ileum. Intraduodenal infusion of lipid (4 h) significantly increased apo AIV immunoreactivity in the jejunum and ileum. Simultaneous intravenous leptin infusion plus duodenal lipid infusion markedly suppressed apo AIV immunoreactivity. Duodenal lipid infusion increased plasma apo AIV significantly (measured by ELISA), whereas simultaneous leptin infusion attenuated the increase. These findings suggest that leptin may regulate circulating apo AIV by suppressing apo AIV synthesis in the small intestine.
small intestine; lipid; immunohistochemistry; enzyme-linked immunosorbent assay
This article has been cited by other articles:
![]() |
C.-M. Lo, M. Xu, Q. Yang, S. Zheng, K. M. Carey, M. R. Tubb, W. S. Davidson, M. Liu, S. C. Woods, and P. Tso Effect of intraperitoneal and intravenous administration of cholecystokinin-8 and apolipoprotein AIV on intestinal lymphatic CCK-8 and apo AIV concentration Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2009; 296(1): R43 - R50. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. H. Hansen, L.-L. Niels-Christiansen, and E. M. Danielsen Leptin and the Obesity Receptor (OB-R) in the Small Intestine and Colon: A Colocalization Study J. Histochem. Cytochem., July 1, 2008; 56(7): 677 - 685. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Lo, D. M. Zhang, K. Pearson, L. Ma, W. Sun, R. R. Sakai, W. S. Davidson, M. Liu, H. E. Raybould, S. C. Woods, et al. Interaction of apolipoprotein AIV with cholecystokinin on the control of food intake Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1490 - R1494. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Glatzle, N. Darcel, A. J. Rechs, T. J. Kalogeris, P. Tso, and H. E. Raybould Apolipoprotein A-IV stimulates duodenal vagal afferent activity to inhibit gastric motility via a CCK1 pathway Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R354 - R359. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Tso, W. Sun, and M. Liu Gastrointestinal Satiety Signals IV. Apolipoprotein A-IV Am J Physiol Gastrointest Liver Physiol, June 1, 2004; 286(6): G885 - G890. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Liu, T. Doi, and P. Tso Regulation of Intestinal and Hypothalamic Apolipoprotein A-IV Experimental Biology and Medicine, November 1, 2003; 228(10): 1181 - 1189. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |